Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
ClinicalTrials.gov study NCT06110663. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer
ClinicalTrials.gov study NCT06986057. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC
ClinicalTrials.gov study NCT06196814. IPD Sharing: NO. Countries: 0. Publications: 0.
Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer
ClinicalTrials.gov study NCT04796454. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Trea
ClinicalTrials.gov study NCT07392060. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05976932. IPD Sharing: NO. Countries: 0. Publications: 0.
LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma
ClinicalTrials.gov study NCT02083536. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
ClinicalTrials.gov study NCT01170650. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors
ClinicalTrials.gov study NCT07272590. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00090675. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After
ClinicalTrials.gov study NCT04267237. IPD Sharing: YES. Countries: 0. Publications: 0.
A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cel
ClinicalTrials.gov study NCT06130007. IPD Sharing: NO. Countries: 0. Publications: 0.
The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients
ClinicalTrials.gov study NCT06102707. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06188455. IPD Sharing: Not stated. Countries: 0. Publications: 0.
CIPN and it's Impact on Quality of Life in Patients Receiving Platinum and Taxanes
ClinicalTrials.gov study NCT05829967. IPD Sharing: Not stated. Countries: 0. Publications: 0.
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT00653952. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC
ClinicalTrials.gov study NCT04983550. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)
ClinicalTrials.gov study NCT06719973. IPD Sharing: NO. Countries: 0. Publications: 0.
Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer
ClinicalTrials.gov study NCT06446206. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Design and Validation of Plasma Proteins and Cytokine Panels to Identify Markers Associated With Response to Niraparib as Maintenance Treatment After First-line Platinum-based Regimen in Patients With
ClinicalTrials.gov study NCT07059676. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.